![Phenylpyrrolidine structural mimics of pirfenidone lacking antifibrotic activity: A new tool for mechanism of action studies - ScienceDirect Phenylpyrrolidine structural mimics of pirfenidone lacking antifibrotic activity: A new tool for mechanism of action studies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014299917303825-gr1.jpg)
Phenylpyrrolidine structural mimics of pirfenidone lacking antifibrotic activity: A new tool for mechanism of action studies - ScienceDirect
![Pharmacometabolic response to pirfenidone in pulmonary fibrosis detected by MALDI-FTICR-MSI | European Respiratory Society Pharmacometabolic response to pirfenidone in pulmonary fibrosis detected by MALDI-FTICR-MSI | European Respiratory Society](https://erj.ersjournals.com/content/erj/52/3/1702314/F4.large.jpg)
Pharmacometabolic response to pirfenidone in pulmonary fibrosis detected by MALDI-FTICR-MSI | European Respiratory Society
June 3, 2015 Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare [Br
![Fibrosi polmonare idiopatica. Arriva in Italia Pirferidone, una speranza per i pazienti - Quotidiano Sanità Fibrosi polmonare idiopatica. Arriva in Italia Pirferidone, una speranza per i pazienti - Quotidiano Sanità](https://i.ytimg.com/vi/P9mLygm_Cz8/mqdefault.jpg)
Fibrosi polmonare idiopatica. Arriva in Italia Pirferidone, una speranza per i pazienti - Quotidiano Sanità
![Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents - ScienceDirect Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X13013176-fx1.jpg)
Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents - ScienceDirect
![È on line nella sezione Revisione bibliografica la relazione “Nintedanib: nuova terapia del Mesotelioma Pleurico Maligno" - È on line nella sezione Revisione bibliografica la relazione “Nintedanib: nuova terapia del Mesotelioma Pleurico È on line nella sezione Revisione bibliografica la relazione “Nintedanib: nuova terapia del Mesotelioma Pleurico Maligno" - È on line nella sezione Revisione bibliografica la relazione “Nintedanib: nuova terapia del Mesotelioma Pleurico](http://www.fondazionebuzziunicem.org/documents/459904/466757/32_9001_nintedanibimg2.jpg/9def540c-b0d3-09a6-d71e-8a797bff9999?t=1548934209875)
È on line nella sezione Revisione bibliografica la relazione “Nintedanib: nuova terapia del Mesotelioma Pleurico Maligno" - È on line nella sezione Revisione bibliografica la relazione “Nintedanib: nuova terapia del Mesotelioma Pleurico
![Design, synthesis and discovery of 2(1H)-quinolone derivatives for the treatment of pulmonary fibrosis through inhibition of TGF-β/smad dependent and independent pathway - ScienceDirect Design, synthesis and discovery of 2(1H)-quinolone derivatives for the treatment of pulmonary fibrosis through inhibition of TGF-β/smad dependent and independent pathway - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523420302269-fx1.jpg)
Design, synthesis and discovery of 2(1H)-quinolone derivatives for the treatment of pulmonary fibrosis through inhibition of TGF-β/smad dependent and independent pathway - ScienceDirect
![Molecular mechanisms of pirfenidone in the reduction in fibrosis. Green... | Download Scientific Diagram Molecular mechanisms of pirfenidone in the reduction in fibrosis. Green... | Download Scientific Diagram](https://www.researchgate.net/profile/Ana-Sandoval-Rodriguez/publication/46109665/figure/fig2/AS:203077073281031@1425428755943/Molecular-mechanisms-of-pirfenidone-in-the-reduction-in-fibrosis-Green-indicates-the_Q320.jpg)